Loading...

PR Information Data

154 개 2 페이지
번호 컨텐츠
139 Gwangju FC and Kuala Lumpur City FC sign mutual business agreement HOT 2025-03-31   110 (주)아디포랩스
138 Gwangju FC and Kuala Lumpur City FC sign mutual business agreement HOT 2025-03-31   109 (주)아디포랩스
137 Korea-Malaysia Relationship Blossoms with High-Frequency Hyperthermia Cancer Treatment Device ‘REMISSION 1℃’ HOT 2025-03-31   107 (주)아디포랩스
136 AdipoLABs Announces REMISSION 1℃ Clinical Results at 6th IVRA HOT 2025-03-31   121 (주)아디포랩스
135 “This is how I overcame cancer” IVRA International Cancer Treatment Seminar launches HOT 2024-07-30   766 (주)아디포랩스
134 Cancer patients should be given the opportunity to make their own choices regarding hyperthermia cancer treatment devices HOT 2024-07-30   740 (주)아디포랩스
133 AdipoLABs takes the lead in physical strength improvement and health care for Gwangju FC soccer players HOT 2024-07-30   848 (주)아디포랩스
132 AdipoLABs successfully cooperates in medical tourism with Sichuan Province, China HOT 2024-07-30   745 (주)아디포랩스
131 Cooperation between Korea and China to promote cancer patient treatment begins in earnest HOT 2024-07-30   723 (주)아디포랩스
130 AdipoLABs discusses the introduction of ‘REMISSION 1℃’ with the Mongolian Ministry of Health and Welfare HOT 2024-07-30   742 (주)아디포랩스
129 High-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’ enters Mongolia in a matter of time HOT 2024-07-26   698 (주)아디포랩스
128 AdipoLABs, Grand Prize at ‘K-First in Class’ for 8 consecutive years HOT 2024-07-26   705 (주)아디포랩스
127 AdipoLABs enters the market with high-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’ HOT 2024-07-11   749 (주)아디포랩스
126 “We will work harder for the development of the country and the company.” HOT 2024-07-11   752 (주)아디포랩스
125 AdipoLABs establishes a bridgehead to enter the Chinese market HOT 2024-07-11   770 (주)아디포랩스